"Designing Growth Strategies is in our DNA"

AI in Drug Repurposing Market Size, Share, and Industry Analysis, By Component (Platforms and Services), By Deployment (Cloud-Based, On Premise, and Hybrid), By Technology (Natural Language Processing (NLP), Machine Learning & Deep Learning, and Others), By Type (Drug Repurposing, Drug Repositioning, Drug Rescue, and Combination Therapies), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), and Others), and Regional Forecast till 2034

Region : Global | Report ID: FBI116772 | Status : Ongoing

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Table of Content:

  • Ongoing
  • 2025
  • 2021-2024
Download Free Sample

    man icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann